Pfizer drug linked to heart problems
A new study by researchers at Wake Forest Baptist Medical Center shows that the use of Pfizer’s ChantixTM, a smoking cessation drug, is associated with a 72 percent increased risk of a serious adverse cardiovascular event, such as heart attack or arrhythmia.
Categories: Research & Discovery, University Announcements
Media Contact
Wake Forest News
media@wfu.edu
336.758.5237
